Apoptotic response of spermatogenic cells to the germ cell mutagens etoposide, adriamycin, and diepoxybutane

Environmental and Molecular Mutagenesis

Volumn 31, Issue 2, 1998, Pages 133-148

  Sjöblom, Tiina ^a   West, Anne ^a   Lähdetie, Jaana ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Apoptosis; In situ end labeling method; ISEL; Mdm2; P21; P53; Rat; Spermatogenesis; Testis

Indexed keywords

BUTADIENE DIEPOXIDE; DOXORUBICIN; ETOPOSIDE; MUTAGENIC AGENT; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DEVELOPMENT; DRUG CARCINOGENICITY; GERM CELL; MALE; MUTAGENICITY; NONHUMAN; RAT; SEMINIFEROUS TUBULE EPITHELIUM; SPERMATOCYTE; SPERMATOGENESIS; TESTIS;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DOXORUBICIN; EPOXY COMPOUNDS; ETOPOSIDE; GENE EXPRESSION; MALE; MUTAGENS; NUCLEAR PROTEINS; PARAFFIN EMBEDDING; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SPERMATOGENESIS; SPERMATOZOA; TESTIS; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 2642608660     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2280(1998)31:2<133::AID-EM5>3.0.CO;2-N     Document Type: Article

References (103)

1. Adler I-D, Anderson D, Benigni R, Ehling U-H, Lähdetie J, Pacchierotti F, Russo A, Tates AD (1996): Synthesis report of the step project detection of germ cell mutagens. Mutat Res 353:65-84.
2. Agarwal ML, Agarwal A, Taylor WR, Stark GR (1995): p53 controls both G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 92:8493-8497.
3. Allan DJ, Roberts SA, Harmon BV (1993): Spontaneous spermatogonial apoptosis shows three distinct morphological phases and no circadian rhythm in the rat. Cell Prolif 25:241-250.
4. Almon E, Goldfinger N, Kapon A, Schwartz D, Levine AJ, Rotter V (1993): Testicular tissue-specific expression of the p53 suppressor gene. Dev Biol 156:107-116.
5. Aloni-Grinstein R, Schwartz D, Rotter V (1995): Accumulation of wild-type p53 protein upon gamma-irradiation induces a G2 arrest-dependent immunoglobulin kappa light chain gene expression. EMBO J 14:1392-1401.
6. Armstrong JF, Kaufman MH, Harrison DJ, Clarke AR (1995): High-frequency developmental abnormalities in p53-deficient mice. Curr Biol 5:931-936.
7. Arnheim N (1979): Characterization of the mouse ribosomal gene fragments purified by nuclear cloning. Gene 7:83-96.
8. Bae I, Smith ML, Fornace AJ Jr (1995): Induction of p53-, mdm2- and WAF1/CIP1-like molecules in insect cells by DNA damaging agents. Exp Cell Res 217:541-545.
9. Billig H, Furuta I, Hsuesh AJW (1993): Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinology 133:2204-2212.
10. Blanco-Rodriguez J, Martinez-Garcia C (1996): Spontaneous germ cell death in the testis of the adult rat takes the form of apoptosis: Re-evaluation of cell types that exhibit the ability to die during spermatogenesis. Cell Prolif 29:13-31.
11. Brinkworth MH, Weinbauer GF, Schlatt S, Nieschlag E (1995): Identification of male germ cells undergoing apoptosis in adult rats. J Reprod Fertil 105:25-33.
12. Buchbinder L, Talbott R, Velasco-Miguel S, Takenaka B, Faha B, Seizinger BR, Kley N (1995): Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646-649.
13. Chatterjee S, Trivedi D, Petzold SJ, Berger NA (1990): Mechanism of epipodophyllotoxin-induced cell death in poly(adenosine diphosphate-ribose) synthesis-deficient V79 Chinese hamster cell lines. Cancer Res 50:2713-2718.
14. Chen CY, Oliner JD, Zhan Q, Fornace AJ Jr, Vogelstein B, Kastan MB (1994): Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc Natl Acad Sci USA 91:2684-2688.
15. Chen GL, Yang L, Rowe TC, Halligan BD, Tewey KM, Liu LF (1984): Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian topoisomerase II. J Biol Chem 259:13560-13566.
16. Chen X, Ko LJ, Jayaraman L, Prives C (1996): p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev 10:2438-2451.
17. Chomczynski P, Sacchi N (1987): Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
18. Clarke DJ, Johnson RT, Downes CS (1993): Topoisomerase II inhibition prevents anaphase chromatid segregation in mammalian cells independently of the generation of DNA strand breaks. J Cell Sci 105:563-569.
19. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH (1993): Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849-852.
20. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH, Reid BJ (1995): A p53-dependent mouse spindle checkpoint. Science 267:1353-1356.
21. Di Leonardo A, Linke SP, Clarkin K, Wahl GM (1994): DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev 8:2540-2551.
22. DiNardo S, Voelkel K, Sternlanz R (1984): DNA topoisomerase II mutant of Saccharomyces cerevisiae: Topoisomerease II is required for segregation of daughter molecules at the termination of DNA replication. Proc Natl Acad Sci USA 81:2616-2620.
23. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A (1992): Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-221.
24. Downes CS, Mullinger AM, Johnson RT (1991): Inhibitors of topoisomerase II prevent chromatid separation in mammalian cells but do not prevent exit from mitosis. Proc Natl Acad Sci USA 88:8895-8899.
25. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993): WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
26. Fearnhead HO, Chwalinski M, Snowden RT, Ormerod MG, Cohen GM (1994): Dexamethasone and etoposide induce apoptosis in rat thymocytes from different phases of the cell cycle. Biochem Pharmacol 48:1073-1079.
27. Fritsche M, Haessler C, Brandner G (1993): Induction of nuclear accumulation of the tumor suppressor protein p53 by DNA damaging agents. Oncogene 8:307-318.
28. Gannon JV, Greaves R, Iggo R, Lane DP (1990): Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 9:1595-1602.
29. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992): Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501.
30. Gorczyca W, Gong J, Darzynkiewicz Z (1993): Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 53:1945-1951.
31. CIP1/WAF1 expression in human epithelial cells. Oncogene 11:253-261.
32. Guillouf C, Rosselli F, Krishnaraju K, Moustacchi E, Hoffman B, Liebermann DA (1995): p53 involvement in control of G2 exit of the cell cycle: Role in DNA damage-induced apoptosis. Oncogene 10:2263-2270.
33. Haapajärvi T, Kivinen L, Pitkànen K, Laiho M (1995): Cell cycle dependent effects of u.v.-radiation on p53 expression and retinoblastoma protein phosphorylation. Oncogene 11:151-159.
34. Hakovirta H, Parvinen M, Lähdetie J (1993): Effects of etoposide on stage-specific DNA synthesis during rat spermatogenesis. Mutat Res 301:189-193.
35. Han K-A, Kulesz-Martin MF (1992): Alternatively spliced p53 RNA in transformed and normal cells of different tissue types. Nucleic Acids Res 20:1979-1981.
36. Harper JW, Elledge SJ, Keymarsi K, Dynlact B, Tsai L, Zhang P, Dobrolowski S, Bai C, Connell-Crowley L, Swindell E, Fox MP, Wei N (1995): Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 6:387-400.
37. Henriksén K, Hakovirta H, Parvinen M (1995a): In-situ quantification of stage-specific apoptosis in the rat seminiferous epithelium: Effects of short term experimental cryptorchidism. Int J Androl 18:256-262.
38. Henriksén K, Hakovirta H, Parvinen M (1995b): Testosterone inhibits and induces apoptosis in rat seminiferous tubules in a stage-specific manner: In situ quantification in squash preparations after administration of ethane dimethane sulfonate. Endocrinology 136:3285-3291.
39. Henriksén K, Kangasniemi M, Parvinen M, Kaipia A, Hakovirta H (1996a): In vitro, follicle-stimulating hormone prevents apoptosis and stimulates deoxyribonucleic acid synthesis in the rat seminiferous epithelium in a stage-specific manner. Endocrinology 137:2141-2149.
40. Henriksén K, Kulmala J, Toppari J, Mehrotra K, Parvinen M (1996b): Stage-specific apoptosis in the rat seminiferous epithelium: Quantification of irradiation effects. J Androl 17:394-401.
41. Hsiang Y-H, Wu H-Y, Liu LF (1988): Topoisomerase: Novel target in cancer chemotherapy. Biochem Pharmacol 37:1801-1802.
42. Huckins C (1978): The morphology and kinetics of spermatogonial degeneration in normal adult rats: An analysis using a simplified classification of germinal epithelium. Anat Rec 190:905-926.
43. Huckins C, Oakberg EF (1978): Morphological and quantitative analysis of spermatogonia in mouse testes using whole mounted seminiferous tubules. I. The normal testes. Anat Rec 192:519-528.
44. Huppi K, Siwarski D, Dosik J, Michieli P, Chedid M, Reed S, Mock B, Givol D, Mushinski JF (1994): Molecular cloning, sequencing, chromosomal localization and expression of mouse p21 (Waf1). Oncogene 9:3017-3020.
45. Jelitto B, Vangala RR, Laib RJ (1989): Species differences in DNA damage by Butadiene: Role of diepoxybutane. Arch Toxicol 13:246-249.
46. Kallio M, Lähdetie J (1993): Analysis of micronuclei induced in mouse early spermatids by mitomycin C, Vinblastine sulphate, or etoposide using fluorescence in situ hybridization. Mutagenesis 8:561-567.
47. Kallio M, Lähdetie J (1996): Fragmentation of centromeric DNA and prevention of homologous chromosome separation in male mouse meiosis in vivo by the topoisomerase II inhibitor etoposide. Mutagenesis 11:435-443.
48. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991): Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304-6311.
49. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ Jr (1992): A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is detective in ataxia-telangiectasia. Cell 71:587-597.
50. Kerr JFR, Winterford CM, Harmon BV (1994): Apoptosis. Its significance in cancer and cancer therapy. Cancer 73:2013-2023.
51. Ko LJ, Prives C (1996): p53: Puzzle and paradigm. Genes Dev 10:1054-1072.
52. Kulesz-Martin MF, Lisafield B, Huang H, Kisiel ND, Lee L (1994): Endogenous p53 protein generated from wild-type alternatively spliced p53 RNA in mouse epidermal cells. Mol Cell Biol 14:1698-1708.
53. Lähdetie J (1983): Meiotic micronuclei induced by adriamycin in male rats. Mutat Res 119:79-82.
54. Lähdetie J, Keiski A, Suutari A, Toppari J (1994): Etoposide (VP-16) is a potent inducer of micronuclei in male rat meiosis: Spermatid micronucleus test and DNA flow cytometry after etoposide treatment. Environ Mol Mutagen 24:192-202.
55. Lähdetie J, Peltonen K, Sjöblom T (1997): Germ cell mutagenicity of three metabolites of 1,3-butadiene in the rat: Induction of spermatid micronuclei by butadiene mono-, di- and diolepoxides in vivo. Environ Mol Mutagen 29:230-239.
56. Lane DP (1992): Cancer. p53, guardian of the genome. Nature 358:15-16.
57. Leblond CP, Clermont Y (1952): Definition of the stages of the seminiferous epithelium in the rat. Ann NY Acad Sci 55:548-573.
58. 32P-postlabeling. Carcinogenesis 15:1903-1910.
59. Liu LF (1989): DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 58:351-378.
60. Liu LF, Liu CC, Alberts BM (1980): Type II DNA topoisomerases: Enzymes that can unknot a topologically knotted DNA molecule via a reversible double-strand break. Cell 19:697-707.
61. Lowe SW, Ruley HE, Jacks T, Housman DE (1993): p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967.
62. Lu CC, Meistrich ML (1979): Cytotoxic effects of chemotherapeutic drugs on mouse testis cells. Cancer Res 39:3575-3582.
63. MacFarlane M, Jones NA, Dive C, Cohen GM (1996): DNA damaging agents induce both p53-dependent and p53-independent apoptosis in immature thymocytes. Mol Pharmacol 50:900-911.
64. Martin K, Trouche D, Hegemeier, Sorensen TS, La Thangue NB, Kouzarides T (1995): Stimulation of E2F1/DP1 transcriptional activity by mdm2 oncoprotein. Nature 375:691-694.
65. Meek DW (1994): Post-translational modification of p53. Semin Cancer Biol 5:203-210.
66. Miyashita T, Reed JC (1995): Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299.
67. Mizumoto K, Rothman RJ, Farber JL (1994): Programmed cell death (apoptosis) of mouse fibroblasts is induced by the topoisomerase II inhibitor etoposide. Mol Pharmacol 46:890-895.
68. Momand J, Zambetti Gp, Olson DC, George D, Levine AJ (1992): The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245.
69. Montes de Oca Luna R, Tabor A, Eberspaecher H, Hulboy DL, Worth LL, Colman MS, Finlay CA, Lozano G (1996): The organization and expression of the mdm2 gene. Genomics 33:352-357.
70. Nelson WG, Kastan MB (1994): DNA strand breaks: The DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol 14:1815-1823.
71. Oakberg E (1956): A description of spermatogenesis in the mouse and its use in analysis of the cycle of seminiferous epithelium and germ cell renewal. Am J Anat 99:391-413.
72. Okamoto K, Beach D (1994): Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J 13:4816-4822.
73. Onishi Y, Azuma Y, Sato Y, Mizuno Y, Tadakuma T, Kizaki H (1993): Topoisomerase inhibitors induce apoptosis in thymocytes. Biochim Biophys Acta 1175:147-154.
74. Parvinen L-M, Parvinen M (1978): Biochemical studies of the rat seminiferous epithelial wave: DNA and RNA syntheses and effects of adriamycin. Ann Biol Biochem Biophys 18:585-594.
75. Payne CM, Bernstein C, Bernstein H (1995): Apoptosis overview emphasizing the role of oxidative stress, DNA damage and signal-transduction pathways. Leuk Lymphoma 19:43-93.
76. Perry ME, Levine AJ (1993): Tumor-suppressor p53 and the cell cycle. Curr Opin Genet Dev 3:50-54.
77. Perry ME, Piette J, Zawadzki JA, Harvey D, Levine AJ (1993): The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc Natl Acad Sci USA 90:11623-11627.
78. Powell SN, DeFranck JS, Connell P, Eogan M, Preffer F, Dombkowski D, Tang W, Friend S (1995): Differential sensitivity of p53(-) and p53(+) cells to caffeine induced radiosensitization and override of G2 delay. Cancer Res 55:1643-1648.
79. Price BD, Park SJ (1994): DNA damage increases the levels of MDM2 messenger RNA in wtp53 human cells. Cancer Res 54:896-899.
80. Rose D, Thomas W, Holm C (1990): Segregation of recombined chromosomes in meiosis 1 requires DNA topoisomerase II. Cell 60:1009-1017.
81. Ross WE (1985): DNA topoisomerases as targets for cancer therapy. Biochem Pharmacol 34:4191-4195.
82. Schwartz D, Goldfinger N, Rotter V (1993): Expression of p53 protein in spermatogenesis is confined to the tetraploid pachytene primary spermatocytes. Oncogene 8:1487-1494.
83. Sjöblom T, Lähdetie J (1996a): Expression of p53 in normal and γ-irradiated rat testis suggests a role for p53 in meiotic recombination and repair. Oncogene 12:2499-2505.
84. Sjöblom T, Lähdetie J (1996b): Micronuclei are induced in rat spermatids in vitro by 1,2,3,4-diepoxybutane but not by 1,2-epoxy-3-butene and 1,2-dihydroxy-3,4-epoxybutane. Mutagenesis 11:252-528.
85. Sjöblom T, Parvinen M, Lähdetie J (1994): Germ-cell mutagenicity of etoposide: Induction of meiotic micronuclei in cultured rat seminiferous tubules. Mutat Res 323:41-45.
86. Spanò M, Bartoleschi C, Cordelli E, Leter G, Segre L, Mantovani A, Fazzi P, Pacchirotti F (1996): Flow cytometric and histological assessment of 1,2,3,4-diepoxybutane toxicity on mouse spermatogenesis. J Toxicol Environ Health 47:423-441.
87. Stewart N, Hicks GG, Paraskevas F, Mowat M (1995): Evidence for a second cell cycle block at G2/M by p53. Oncogene 10:109-115.
88. Taudou G, Portemer C, Jaxel C, Duguet M (1993): Inhibition of DNA synthesis and DNA fragmentation in stimulated splenocytes by the concerted action of topoisomerase I and II poisons. Biochem Pharmacol 45:331-337.
89. Tewey KM, Rowe TC, Yang L, Halligan BD, Liu LF (1984): Adriamycin-induced DNA damage mediated by mammalian topoisomerase II. Science 226:466-468.
90. Tishler RB, Calderwood SK, Coleman CN, Price BD (1993): Increases in sequence specific binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res 53:2212-2216.
91. Toppari J, Lähdetie J, Härkönen P, Eerola E, Parvinen M (1986): Mutagen effects on rat seminiferous tubules in vitro: Induction of meiotic micronuclei by adriamycin. Mutat Res 171:149-156.
92. Waf1 expression during rat spermatogenesis of the normal and X-irradiated rat. Int J Radiat Biol 71:283-291.
93. Vig BK (1977): Genetic toxicology of mitomycin C, actinomycins, daunorubisin and adriamycin. Mutat Res 39:189-238.
94. White E (1996): Life, death and the pursuit of apoptosis. Genes Dev 10:1-15.
95. Wijsman JH, Jonker RR, Keijser R, Van de Velde CJ, Cornelisse CJ, van Dierendonck JH (1993): A new method to detect apoptosis in paraffin sections: In situ end-labeling of fragmented DNA. J Histochem Cytochem 41:7-12.
96. Wu X, Bayle H, Olson D, Levine AJ (1993): The p53-mdm-2 autoregulatory feedback loop. Genes Dev 7:1126-1132.
97. Wyllie AH (1987): Apoptosis: Cell death in tissue regulation. J Pathol 153:313-316.
98. Xiao Y, Tates AD (1995): Clastogenic effects of 1,3-butadiene and its metaboliles 1,2-epoxybutane and 1,2,3,4-diepoxybutane in splenocytes and germ cells of rats and mice in vivo. Environ Mol Mutagen 26:97-108.
99. Xiao Z-X, Chen J, Levine AJ, Modjtahedi N, Xing J, Sellers WR, Livingston DM (1995): Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375:694-698.
100. Xiong Y, Hannon G, Zhang H, Casso D, Kobayashi R, Beach D (1993): p21 is a universal inhibitor of cyclin dependent kinases. Nature 366:701-704.
101. Zaubermann A, Lubp A, Oren M (1995): Identification of p53 target genes through immune selection of genomic DNA: The cyclin G gene contains two distinct p53 binding sites. Oncogene 10:2361-2366.
102. Zhan Q, Fan S, Bae I, Guillouf C, Liebermann DA, O'Connor PM, Fomace AJ Jr (1994): Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. J Oncogene 9:3743-3751.
103. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valet A, Minty A, Chalon P, Lelias J-M, Dumont X, Ferrara P, McKeon F, Caput D (1997): Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809-819.